article thumbnail

ReGelTec Announces First Patient Treated in U.S. IDE Clinical Trial for HYDRAFIL System to Treat Chronic Low Back Pain

OrthoSpineNews

a company developing a percutaneous hydrogel implant for the treatment of chronic low back pain caused by degenerative disc disease, announced it has treated the first patient in its HYDRAFIL-D FDA investigational device exemption (IDE) clinical trial for its HYDRAFIL ® System for disc augmentation. Jasper, Ga.;

article thumbnail

Locate Your Nearest Sports Injury Chiropractor for Expert Care

Any Spine

Preventing Future Injuries With Proactive Care Preventing future injuries is a key focus in my clinic, especially for athletes who may be prone to conditions like bursitis or degenerative disc disease. Lastly, understanding consent and treatment procedures will help you feel more comfortable and informed about your care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Stay Active & Injury-Free: Chiropractor in Atlanta, Georgia

Any Spine

Observing protected health information, I’ve seen how catching these early symptoms leads to more effective treatment, preventing further damage, and ensuring you can continue your active endeavors free from debilitating pain.

article thumbnail

Dymicron Granted IDE Approval for Triadyme-C Artificial Disc

OrthoSpineNews

Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to begin a pivotal clinical study of the Triadyme ® –C cervical artificial disc. For more information, please contact: Curt Ence Chief Financial Officer 1186 South 1680 West Orem, UT 84058 Email: IR@dymicron.com SOURCE Dymicron Inc.

article thumbnail

Holistic Wellness: Chiropractic and Massage Services Near Me

Any Spine

They illuminate the practitioner’s ability to provide a comforting environment and effective treatments, allowing you to make an informed decision based on experiences mirroring your own health objectives. For more detailed information, consider reviewing our FAQ.

article thumbnail

Spinal Stabilization Technologies™ Announces Enrollment of First U.S. Patient in IDE Trial for PerQdisc™ Nucleus Replacement Device

OrthoSpineNews

based trial to evaluate its PerQdisc system for patients suffering from degenerative disc disease (DDD). For more information, visit: [link] SOURCE Spinal Stabilization Technologies patient in its Investigational Device Exemption (IDE) clinical trial for the PerQdisc Nucleus Replacement Device (NRD).

article thumbnail

Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration

OrthoSpineNews

a leader in developing and delivering innovative allografts, today announced that it has completed subject enrollment in its ASCEND clinical trial evaluating VIA Disc NP for symptomatic degenerative disc disease (DDD), a condition strongly associated with chronic lower back pain. About Vivex Biologics, Inc.